Discovery and evaluation of selective, orally available and brain penetrant inhibitors of leucine rich repeat kinase 2 (LRRK2)

被引：0

作者：

DeMong, Duane ^{[1
]}

Basu, Kallol ^{[1
]}

Scott, Jack ^{[1
]}

Miller, Michael ^{[1
]}

Agnihotri, Gautam ^{[1
]}

Baptista, Marco ^{[1
]}

Cheewatrakoolpong, Boonlert ^{[1
]}

Columbus, John ^{[1
]}

Dai, Xing ^{[1
]}

Duan, Xiaobang ^{[2
]}

Fell, Matthew ^{[1
]}

Frank, Emily ^{[1
]}

Frassetto, Andrea ^{[1
]}

Greshock, Thomas ^{[1
]}

Harris, Joel ^{[1
]}

Hruza, Alan ^{[1
]}

Hu, Zhiyong ^{[1
]}

Li, Wei ^{[1
]}

Lin, Sue-Ing ^{[1
]}

Liu, Hong ^{[1
]}

Macala, Megan ^{[1
]}

Mei, Hong ^{[1
]}

Mirescu, Christian ^{[1
]}

Morrow, John ^{[1
]}

Poirier, Marc ^{[1
]}

Scapin, Giovanna ^{[1
]}

Sherborne, Bradley ^{[1
]}

Smith, Michelle ^{[1
]}

Stevenson, Heather ^{[1
]}

Strickland, Corey ^{[1
]}

Tempest, Paul ^{[2
]}

Vicarel, Monica ^{[1
]}

Walsh, Paul ^{[1
]}

Xiao, Li ^{[1
]}

Zhang, Honglu ^{[1
]}

Zhou, Xiaoping ^{[1
]}

Duffy, Joseph ^{[1
]}

Kennedy, Matthew ^{[1
]}

McCauley, John ^{[1
]}

Nargund, Ravi ^{[1
]}

Parker, Eric ^{[1
]}

Ruck, Rebecca ^{[1
]}

Stamford, Andrew ^{[1
]}

Weber, Ann ^{[1
]}

机构：

[1] Merck & Co Inc, Merck Res Labs, Somerset, NJ USA

[2] Shanghai Chempartner, Shanghai, Peoples R China

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[1] Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors
Greshock, Thomas J.
Sanders, John M.
Drolet, Robert E.
Rajapakse, Hemaka A.
Chang, Ronald K.
Kim, Boyoung
Rada, Vanessa L.
Tiscia, Heather E.
Su, Hua
Lai, Ming-Tain
Sur, Sylvie M.
Sanchez, Rosa I.
Bilodeau, Mark T.
Renger, John J.
Kern, Jonathan T.
McCauley, John A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2631 - 2635
[2] Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
Estrada, Anthony A.
Chan, Bryan K.
Baker-Glenn, Charles
Beresford, Alan
Burdick, Daniel J.
Chambers, Mark
Chen, Huifen
Dominguez, Sara L.
Dotson, Jennafer
Drummond, Jason
Flagella, Michael
Fuji, Reina
Gill, Andrew
Halladay, Jason
Harris, Seth F.
Heffron, Timothy P.
Kleinheinz, Tracy
Lee, Donna W.
Le Pichon, Claire E.
Liu, Xingrong
Lyssikatos, Joseph P.
Medhurst, Andrew D.
Moffat, John G.
Nash, Kevin
Scearce-Levie, Kimberly
Sheng, Zejuan
Shore, Daniel G.
Wong, Susan
Zhang, Shuo
Zhang, Xiaolin
Zhu, Haitao
Sweeney, Zachary K.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) : 921 - 936
[3] Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Gulati, Anmol
Yeung, Charles S.
Lapointe, Blair
Kattar, Solomon D.
Gunaydin, Hakan
Scott, Jack D.
Childers, Kaleen K.
Methot, Joey L.
Simov, Vladimir
Kurukulasuriya, Ravi
Pio, Barbara
Morriello, Greg J.
Liu, Ping
Tang, Haiqun
Neelamkavil, Santhosh
Wood, Harold B.
Rada, Vanessa L.
Ardolino, Michael J.
Yan, Xin Cindy
Palte, Rachel
Otte, Karin
Faltus, Robert
Woodhouse, Janice
Hegde, Laxminarayan G.
Ciaccio, Paul
Minnihan, Ellen C.
DiMauro, Erin F.
Fell, Matthew J.
Fuller, Peter H.
Ellis, J. Michael
RSC MEDICINAL CHEMISTRY, 2021, 12 (07): : 1164 - 1173
[4] Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
Estrada, Anthony A.
Liu, Xingrong
Baker-Glenn, Charles
Beresford, Alan
Burdick, Daniel J.
Chambers, Mark
Chan, Bryan K.
Chen, Huifen
Ding, Xiao
Di Pasquale, Antonio G.
Dominguez, Sara L.
Dotson, Jennafer
Drummond, Jason
Flagella, Michael
Flynn, Sean
Fuji, Reina
Gill, Andrew
Gunzner-Toste, Janet
Harris, Seth F.
Heffron, Timothy P.
Kleinheinz, Tracy
Lee, Donna W.
Le Pichon, Claire E.
Lyssikatos, Joseph P.
Medhurst, Andrew D.
Moffat, John G.
Mukund, Susmith
Nash, Kevin
Scearce-Levie, Kimberly
Sheng, Zejuan
Shore, Daniel G.
Thuy Tran
Trivedi, Naimisha
Wang, Shumei
Zhang, Shuo
Zhang, Xiaolin
Zhao, Guiling
Zhu, Haitao
Sweeney, Zachary K.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9416 - 9433
[5] Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
Estrada, Anthony A.
Sweeney, Zachary K.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) : 6733 - 6746
[6] Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
Scott, Jack D.
DeMong, Duane E.
Greshock, Thomas J.
Basu, Kallol
Dai, Xing
Harris, Joel
Hruza, Alan
Li, Sarah W.
Lin, Sue-Ing
Liu, Hong
Macala, Megan K.
Hu, Zhiyong
Mei, Hong
Zhang, Honglu
Walsh, Paul
Poirier, Marc
Shi, Zhi-Cai
Xiao, Li
Agnihotri, Gautam
Baptista, Marco A. S.
Columbus, John
Fell, Matthew J.
Hyde, Lynn A.
Kuvelkar, Reshma
Lin, Yinghui
Mirescu, Christian
Morrow, John A.
Yin, Zhizhang
Zhang, Xiaoping
Zhou, Xiaoping
Chang, Ronald K.
Embrey, Mark W.
Sanders, John M.
Tiscia, Heather E.
Drolet, Robert E.
Kern, Jonathan T.
Sur, Sylvie M.
Renger, John J.
Bilodeau, Mark T.
Kennedy, Matthew E.
Parker, Eric M.
Stamford, Andrew W.
Nargund, Ravi
McCauley, John A.
Miller, Michael W.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 2983 - 2992
[7] Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) - Part 1
Osbornea, Joanne
Birchall, Kristian
Tsagris, Denise J.
Lewis, Stephen J.
Smiljanic-Hurley, Ela
Taylor, Debra L.
Levy, Alison
Alessi, Dario R.
McIver, Edward G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (04) : 668 - 673
[8] Screening and structural strategies for the design of selective Leucine-rich repeat kinase 2 (LRRK2) inhibitors
Chen, Ijen
David, Laurent
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[9] Discovery and development of potent, selective, and brain-penetrant LRRK2 kinase inhibitors for Parkinson's disease
De Vicente, Javier
Dresser, Mark
Estrada, Anthony
Feng, Jianwen
Henry, Anastasia
Ho, Carole
Huntwork-Rodriguez, Sarah
Negrou, Ella
Poda, Suresh
Scearce-Levie, Kimberly
Solanoy, Hilda
Sweeney, Zachary
Tonn, George
He, Jianrong
Zhang, Rui
Xu, Musheng
Wong, Bradley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[10] Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Keylor, Mitchell H.
Gulati, Anmol
Kattar, Solomon D.
Johnson, Rebecca E.
Chau, Ryan W.
Margrey, Kaila A.
Ardolino, Michael J.
Zarate, Cayetana
Poremba, Kelsey E.
Simov, Vladimir
Morriello, Gregori J.
Acton, John J.
Pio, Barbara
Yan, Xin
Palte, Rachel L.
McMinn, Spencer E.
Nogle, Lisa
Lesburg, Charles A.
Adpressa, Donovon
Lin, Shishi
Neelamkavil, Santhosh
Liu, Ping
Su, Jing
Hegde, Laxminarayan G.
Woodhouse, Janice D.
Faltus, Robert
Xiong, Tina
Ciaccio, Paul J.
Piesvaux, Jennifer
Otte, Karin M.
Wood, Harold B.
Kennedy, Matthew E.
Bennett, David Jonathan
DiMauro, Erin F.
Fell, Matthew J.
Fuller, Peter H.
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (01) : 838 - 856

← 1 2 3 4 5 →